CLOSE

Dialog Box

Loading...

international Speakers


NEAL S. YOUNG, M.D. 

CHIEF HAEMATOLOGY BRANCH,
NATIONAL HEART, BLOOD AND LUNG INSTITUTE, 
NATIONAL INSTITUTES OF HEALTH (nih), BETHESDA, MARYLAND U.S.A. 

Neal S. Young, M.D., is a world expert in the study of bone marrow failure. His clinical and research interests include aplastic anemia, telomeropathies and other inherited bone marrow failure syndromes, myelodysplastic syndromes, paroxysmal nocturnal hemoglobinuria, and parvovirus B19.  


His scientific investigations have spanned basic science and translational research, epidemiology and molecular biology, and especially pivotal clinical treatment protocols. His work has led to understanding the pathophysiology of aplastic anemia as immune-mediated and the development of effective immunotherapy that has dramatically improved survival in this devastating disease.

Most recently, his group has discovered that eltrombopag can stimulate hematopoetic stem cells in bone marrow failure and and that danazo is both effective in the treatment of telomeropathies and elongates telomeres.  

 During the course of his career, he has trained over 100 postdoctoral and clinical fellows and mentored many junior faculty members.  He has published over 500 original research articles, reviews, book chapters, and monographs.  

 

dr ALISON BERTUCH 

associate professor of paediatric haematology/oncology and molecular & human genetics, baylor college of medicine.  

Director of the Bone Marrow Failure Program at Texas Children's Hospital   

Dr. Bertuch is the director of the Bone Marrow Failure Program at Texas Children’s Hospital, the largest children’s hospital and among the top-ranked paediatric haematology/oncology centres in the United States. She is also Associate Professor of Pediatric Hematology/Oncology and Molecular & Human Genetics at Baylor College of Medicine. 

She has a long-standing interest in telomere biology and her research contributions have spanned from the basic science of telomeres to translational and clinical studies on the telomere biology disorders, such as the bone marrow failure predisposition syndrome dyskeratosis congenita. She is particularly interested in the complexity of the molecular genetics underlying these disorders.

Dr. Bertuch has served in several leadership roles including as a Co-leader of the Clinical Care Consortium for Telomere Associated Ailments, as an inaugural Executive Committee member of the North American Pediatric Aplastic Anemia Consortium, and recent Chairperson of the American Society of Hematology Scientific Committee on Bone Marrow Failure. She is on the Medical Advisory Board of Team Telomere and the Scientific Advisory Board of the Shwachman-Diamond Syndrome Registry. She has received several honors including election to the American Society for Clinical Investigation and the American Pediatric Society.